Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 2 Nasopharyngeal Carcinoma 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma 2 Lung Neoplasms 2 Carcinoma, Hepatocellular 2 Advanced Solid Tumor 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Pheochromocytoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Paraganglioma, Extra-Adrenal 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma Metastatic 1 Osteosarcoma 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 Nasopharyngeal Neoplasms 1 Locally Advanced or Metastatic Radioiodine-refractory Differentiated Thyroid Carcinoma 1 Gynecological Cancer 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Esophageal Squamous Cell Carcinoma 1 Digestive System Diseases 1

Interventions

Iodine-131 21 lenvatinib 17 Magnetic Resonance Spectroscopy 17 trametinib 13 Sorafenib 13 Thyrotropin Alfa 12 pembrolizumab 11 dabrafenib 11 Thyroidectomy 10 Surgical Procedures, Operative 10 Thyroxine 9 Paclitaxel 9 vandetanib 8 selpercatinib 8 Sunitinib 7 Nivolumab 7 Fluorodeoxyglucose F18 7 cabozantinib 6 anlotinib 6 Everolimus 6 Biopsy 6 pazopanib 5 Vemurafenib 5 Triiodothyronine 5 Specimen Handling 5 Saline Solution 5 Radiotherapy 5 Radiofrequency Ablation 5 Iodine-124 5 Cyclophosphamide 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thyroid Neoplasms × penpulimab × Clear all

NCT04952493 2022-01-28

Anlotinib or Penpulimab in Combination With RAI for DTC

Peking Union Medical College Hospital

Phase 2 Unknown

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡